| Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Seidelmann Scott Peter | EVP, CHIEF COMMERCIAL OFFICER | Jun 16 | Sale | 110.15 | 3,765 | 414,732 | 40,789 | Jun 17 05:11 PM | | PARRISH MARK W | Director | Apr 06 | Option Exercise | 14.87 | 2,000 | 29,740 | 46,558 | Apr 08 04:07 PM | | PARRISH MARK W | Director | Mar 25 | Option Exercise | 14.87 | 2,000 | 29,740 | 44,558 | Mar 28 04:15 PM | | Seidelmann Scott Peter | EVP, Chief Commercial Officer | Mar 16 | Sale | 133.11 | 2,525 | 336,103 | 48,380 | Mar 16 04:29 PM | | PARRISH MARK W | Director | Mar 10 | Option Exercise | 14.87 | 2,000 | 29,740 | 42,558 | Mar 11 05:24 PM | | PARRISH MARK W | Director | Feb 18 | Option Exercise | 14.87 | 3,000 | 44,610 | 40,558 | Feb 22 07:04 PM | | PARRISH MARK W | Director | Feb 15 | Option Exercise | 0.00 | 3,000 | 0 | 37,558 | Feb 15 07:06 PM | | Moore Vance B. | Director | Feb 10 | Option Exercise | 0.00 | 25,951 | 0 | 67,218 | Feb 10 05:44 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Dec 16 | Sale | 176.88 | 1,063 | 188,019 | 25,831 | Dec 16 05:57 PM | | Seidelmann Scott Peter | EVP, Chief Commercial Officer | Dec 16 | Sale | 176.90 | 3,628 | 641,778 | 33,632 | Dec 16 05:57 PM | | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | Dec 08 | Sale | 180.76 | 6,976 | 1,260,953 | 9,399 | Dec 08 06:34 PM | | Kuipers Peter J. | Executive V P& CFO | Dec 07 | Option Exercise | 0.00 | 5,640 | 0 | 59,592 | Dec 08 06:35 PM | | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | Dec 07 | Sale | 181.14 | 1,179 | 213,564 | 16,375 | Dec 08 06:34 PM | | Kuipers Peter J. | Executive V P& CFO | Dec 07 | Sale | 181.15 | 8,517 | 1,542,860 | 51,075 | Dec 08 06:35 PM | | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | Nov 16 | Option Exercise | 0.00 | 38,585 | 0 | 56,139 | Nov 17 11:50 AM | | SPEARS JOSEPH BRIAN | Chief Accounting Officer & VP | Nov 16 | Sale | 180.36 | 38,585 | 6,959,336 | 17,554 | Nov 17 11:50 AM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Nov 02 | Option Exercise | 0.00 | 5,358 | 0 | 34,334 | Nov 02 07:08 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Nov 02 | Sale | 180.00 | 5,358 | 964,440 | 28,976 | Nov 02 07:08 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Oct 26 | Option Exercise | 0.00 | 10,451 | 0 | 39,427 | Oct 27 12:54 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Oct 26 | Sale | 170.00 | 10,451 | 1,776,670 | 28,976 | Oct 27 12:54 PM | | Judson James T | Director | Aug 23 | Sale | 153.00 | 4,984 | 762,551 | 18,336 | Aug 23 07:06 PM | | Seim Robin Gene | Director | Aug 09 | Sale | 151.60 | 6,686 | 1,013,586 | 30,049 | Aug 10 05:33 PM | | Kuipers Peter J. | Executive V P& CFO | Aug 06 | Option Exercise | 0.00 | 5,640 | 0 | 65,452 | Aug 06 07:49 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Aug 06 | Option Exercise | 0.00 | 5,094 | 0 | 33,823 | Aug 06 07:48 PM | | Kuipers Peter J. | Executive V P& CFO | Aug 06 | Sale | 157.88 | 11,500 | 1,815,636 | 53,130 | Aug 06 07:49 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Aug 06 | Sale | 160.00 | 5,094 | 815,040 | 28,729 | Aug 06 07:48 PM | | Seidelmann Scott Peter | EVP, Chief Commercial Officer | Aug 05 | Option Exercise | 0.00 | 38,250 | 0 | 82,267 | Aug 06 05:48 PM | | Seidelmann Scott Peter | EVP, Chief Commercial Officer | Aug 05 | Sale | 153.05 | 41,878 | 6,409,291 | 40,389 | Aug 06 05:48 PM | | Kuipers Peter J. | Executive V P& CFO | Aug 02 | Option Exercise | 0.00 | 15,587 | 0 | 81,909 | Aug 03 04:21 PM | | Kuipers Peter J. | Executive V P& CFO | Aug 02 | Sale | 146.11 | 22,097 | 3,228,619 | 59,812 | Aug 03 04:21 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Jul 20 | Option Exercise | 0.00 | 24,489 | 0 | 59,965 | Jul 21 04:29 PM | | JOHNSTON DAN S | EVP & Chief Legal & Admin | Jul 20 | Sale | 151.35 | 31,236 | 4,727,707 | 28,729 | Jul 21 04:29 PM |
|
